ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » District of Columbia » Internal Medicine

Top Internal Medicine Prescribers in District of Columbia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SHEWIT BEZABEH MD

Internal Medicine

234

$3,346

163
65 are 65+

14%
patients receiving schedule two controlled substances

Avg: 4%

44%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 29%

$14
Average prescription price

Avg: $77

PATRICIA WRIGHT M.D.

Internal Medicine

275

$56.8K

27
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 29%

$206
Average prescription price

Avg: $77

FIDELIS DOH MD

Internal Medicine

291

$20.8K

51
0 are 65+

35%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 29%

$72
Average prescription price

Avg: $77

ASHWINI SARDANA MD

Internal Medicine

449

$8,255

243
130 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

30%
patients receiving schedule three controlled substances

Avg: 5%

17%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 29%

$18
Average prescription price

Avg: $77

MIRIAM CAMERON MD

Internal Medicine

482

$522K

49
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

65%
prescriptions for brand name drugs

Avg: 29%

$1083
Average prescription price

Avg: $77

ROBERT DIBBLE M.D.

Internal Medicine

526

$53K

52
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 29%

$101
Average prescription price

Avg: $77

CHI-HYUN KIM MD

Internal Medicine

539

$19.6K

56
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 29%

$36
Average prescription price

Avg: $77

TONJA GADSDEN MD

Internal Medicine

541

$32.4K

43
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 29%

$60
Average prescription price

Avg: $77

MARGOT WHEELER

Internal Medicine

544

$33.2K

35
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$61
Average prescription price

Avg: $77

LAURIE LETARTE MD

Internal Medicine

570

$22.7K

56
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 29%

$40
Average prescription price

Avg: $77

DAGOBERT SIMO MD

Internal Medicine

614

$20.2K

42
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 29%

$33
Average prescription price

Avg: $77

BETH UNGAR M.D.

Internal Medicine

616

$58.2K

60
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 29%

$94
Average prescription price

Avg: $77

ALICE FUISZ M.D.

Internal Medicine

646

$52.2K

52
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 29%

$81
Average prescription price

Avg: $77

LISA KAUFMAN M.D.

Internal Medicine

650

$54.2K

70
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$83
Average prescription price

Avg: $77

JILLIAN CATALANOTTI M.D., M.P.H.

Internal Medicine

701

$65.8K

73
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$94
Average prescription price

Avg: $77

ANNA ZAMSKAYA M.D.

Internal Medicine

732

$45K

87
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 29%

$62
Average prescription price

Avg: $77

ELLIOT ALESKOW MD

Internal Medicine

774

$74.1K

81
76 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 29%

$96
Average prescription price

Avg: $77

DARCY HANSEN M.D.

Internal Medicine

804

$75.7K

50
48 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 29%

$94
Average prescription price

Avg: $77

CHANIGAN NILUBOL M.D.

Internal Medicine

811

$106K

51
13 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 29%

$131
Average prescription price

Avg: $77

CHARLES POTTS MD

Internal Medicine

814

$49.9K

23
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 29%

$61
Average prescription price

Avg: $77

PETER BASCH M.D.

Internal Medicine

816

$58.9K

51
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 29%

$72
Average prescription price

Avg: $77

MARY FISHMAN

Internal Medicine

825

$49.6K

66
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$60
Average prescription price

Avg: $77

ASHLEY MCCLURE MD

Internal Medicine

826

$34.1K

83
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 29%

$41
Average prescription price

Avg: $77

NICOLE SINGH MD

Internal Medicine

852

$79K

65
57 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 29%

$93
Average prescription price

Avg: $77

RACHEL KON MD

Internal Medicine

854

$59.6K

76
40 are 65+

18%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$70
Average prescription price

Avg: $77

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank